Healthcare Business International interviews Nelson Advisors discussing the Hims & Hers acquisition of Eucalyptus

2 hours ago4 min read

How could the Software sell off and AI bubble in early 2026 affect Digital Health, HealthTech and MedTech funding and M&A for the rest of 2026?

8 hours ago13 min read

The Strategic Evolution of European Healthcare Investment Banking: A Definitive Analysis of Nelson Advisors and the Specialised Boutique Ascendancy

9 hours ago15 min read

FemTech's transition from fragmented Venture Capital category into Women’s Health and pillar of Global Healthcare Acquisition strategies

1 day ago12 min read

The 2026 Biopharmaceutical M&A Renaissance: Strategic Consolidation Amidst Patent Volatility and Technological Convergence

1 day ago13 min read

Every Cure and Computational Pharmacophenomics: A New Field of Medicine

2 days ago10 min read

Doctolib's Potential 3 Year Strategic Outlook 2026 to 2028: IPO, AI and International Expansion

3 days ago14 min read

Founder Bankers and Taxonomy of European Healthcare Technology Investment Banking Specialists

5 days ago10 min read

Future Billion Dollar HealthTech and MedTech Sectors

6 days ago13 min read

This Week in European MedTech and HealthTech: 20th February 2026

6 days ago4 min read

Global Health Convergence: Analysis of the $1.15 Billion Acquisition of Eucalyptus by Hims & Hers Health

6 days ago12 min read

Analysis of Germany’s Federal Ministry of Health Digitalisation Strategy for Health and Care 2026

Feb 1810 min read

Agentic Siri from Apple benefits for Healthcare Technology

Feb 1811 min read

OpenClaw + OpenAI's potential for Healthcare Technology in 2026

Feb 1811 min read

The Sensor Driven Transformation of MedTech: Danaher’s $10 Billion Strategic Integration of Masimo

Feb 1714 min read